Published 23 December 2020 Detection of an epidemiological cluster associated with a new variant of concern 1. Working with academic collaborators at the University of Oxford, PHE Porton Down has been evaluating the performance of lateral flow devices (LFDs) since mid-August 2020. Over 60 have been considered to date, approximately 30% of which have progressed to extended evaluation […]
Variant of Concern 202012/01 Detection of an epidemiological cluster associated with a new variant of concern Analysis of routinely available genomic data in Kent, England was undertaken as part of an epidemiological investigation to investigate increasing incidence on 8 December 2020. Although only 4% (255/6130) of Kent cases had available genomes through COG-UK sequencing, a […]
Full-text Download View Knowledge Base – Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro — A comparison of PCR vs Immunoassay vs Crispr-Based test>> Author:Huajun Bai1 Xiaolong Cai1, 2* Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by […]
Full-text Download View Knowledge Base – Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro — A comparison of PCR vs Immunoassay vs Crispr-Based test>> Author:Huajun Bai1 Xiaolong Cai1, 2* Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by […]
Full-text Download View Knowledge Base – Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro — A comparison of PCR vs Immunoassay vs Crispr-Based test>> Author:Huajun Bai1 Xiaolong Cai1, 2* Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by […]
Author:Huajun Bai1 Xiaolong Cai1, 2* Xiaoyan Zhang11. R&D Center, GeneMedi Co.Ltd., Shanghai, P.R. China (www.genemedi.com)2. Hanbio Research Center, Hanbio Tech Co. Ltd., Shanghai, P.R. China (www.hanbio.net) Abstract:The outbreak of COVID-19, caused by 2019 novel coronavirus (2019-nCoV), has been a global public health threat and caught the worldwide concern. Scientists throughout the world are sparing all efforts to […]
Technical briefing 10 7 May 2021 This briefing provides an update on previous briefings up to 1 April 2021 Summary •There are 5 variants of concern and 8 variants under investigation (Table 1). VUI-21APR-02 (B.1.617.2) was escalated to a variant of concern on 6 May 2021 (VOC21APR-02). It is assessed as having at least equivalent […]
The world is in midst of the COVID-19 pandemic. Recently a new SARS-CoV-2 (2019nCOV)lineage (B.1.526) emerged in New York and spread rapidly. The New York variant B.1.526 lineage is characterised by six lineage-defining mutations in the spike protein, including D614G mutation and one at important residues in the receptor-binding domain (S477N or E484K)1.The combination of […]
The world is in midst of the COVID-19 pandemic. Recently A new “double mutant” variant of the coronavirus has been detected from samples collected in India. The two mutations (E484Q and L452R mutations) come together in the same virus, may be more infectious or less affected by vaccines.1 GeneMedi pseudotype virus (pseudovirus) of SARS-COV-2 (2019nCOV) […]
Technical briefing 14 3 June 2021 This briefing provides an update on previous briefings up to 27 May 2021 Summary There are 5 variants of concern and 9 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of Delta (VOC21APR-02, B.1.617.2). A separate report is published covering our […]
